Search research articles
Contact Us
Filters
Showing results (1-10 of 136) with videos related to
Page
of 14
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Maintenance therapy for myeloma: how much, how long, and at what cost?
Michel Attal, Murielle Roussel
Hematology. American Society of Hematology. Education Program
|
February 20, 2015
All transplantation-eligible patients with myeloma should receive ASCT in first response
Philippe Moreau, Michel Attal
Blood Reviews
|
September 28, 2002
The role of stem cell transplantation in multiple myeloma
Jean-Luc Harousseau, Michel Attal
Blood
|
July 7, 2017
How I treat first relapse of myeloma
Jean Luc Harousseau, Michel Attal
Seminars in Hematology
|
April 25, 2009
The role of high-dose therapy with autologous stem cell support in the era of novel agents
Michel Attal, Jean-Luc Harousseau
Best Practice & Research. Clinical Haematology
|
December 12, 2007
Role of autologous stem-cell transplantation in multiple myeloma
Michel Attal, Jean-Luc Harousseau
Blood
|
April 4, 2015
Frontline therapy of multiple myeloma
Philippe Moreau, Michel Attal, Thierry Facon
European Journal of Haematology
|
March 11, 2010
Vitamin D deficiency does not alter biochemical markers of bone metabolism before or after autograft in patients with multiple myeloma
Michel Laroche, Olivia Lemaire, Michel Attal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2011
Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival
Antonio Palumbo, Michel Attal, Murielle Roussel
Blood
|
July 30, 2009
The role of complete response in multiple myeloma
Jean-Luc Harousseau, Michel Attal, Herve Avet-Loiseau
Page
of 14
Search research articles
Search
Showing results (1-10 of 136) with videos related to
Sort By:
Page
of 14
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Maintenance therapy for myeloma: how much, how long, and at what cost?
Michel Attal, Murielle Roussel
Hematology. American Society of Hematology. Education Program
|
February 20, 2015
All transplantation-eligible patients with myeloma should receive ASCT in first response
Philippe Moreau, Michel Attal
Blood Reviews
|
September 28, 2002
The role of stem cell transplantation in multiple myeloma
Jean-Luc Harousseau, Michel Attal
Blood
|
July 7, 2017
How I treat first relapse of myeloma
Jean Luc Harousseau, Michel Attal
Seminars in Hematology
|
April 25, 2009
The role of high-dose therapy with autologous stem cell support in the era of novel agents
Michel Attal, Jean-Luc Harousseau
Best Practice & Research. Clinical Haematology
|
December 12, 2007
Role of autologous stem-cell transplantation in multiple myeloma
Michel Attal, Jean-Luc Harousseau
Blood
|
April 4, 2015
Frontline therapy of multiple myeloma
Philippe Moreau, Michel Attal, Thierry Facon
European Journal of Haematology
|
March 11, 2010
Vitamin D deficiency does not alter biochemical markers of bone metabolism before or after autograft in patients with multiple myeloma
Michel Laroche, Olivia Lemaire, Michel Attal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2011
Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival
Antonio Palumbo, Michel Attal, Murielle Roussel
Blood
|
July 30, 2009
The role of complete response in multiple myeloma
Jean-Luc Harousseau, Michel Attal, Herve Avet-Loiseau
Page
of 14